Free cash flow · 2019–2025
Organon free cash flow
$538M−29.6% · FY2025
Organon (OGN) reported $538M in free cash flow for fiscal 2025, −29.6% year on year.
| Fiscal year | Free cash flow | Change | Filing |
|---|---|---|---|
| FY2025 | $538M | −29.6% | Derived |
| FY2024 | $764M | +39.4% | Derived |
| FY2023 | $548M | −17.2% | Derived |
| FY2022 | $662M | −66.4% | Derived |
| FY2021 | $2.0B | −3.0% | Derived |
| FY2020 | $2.0B | −30.7% | Derived |
| FY2019 | $2.9B | — | Derived |
Free cash flow — Free cash flow is operating cash flow minus capital expenditure: what is left once the company has paid to maintain and expand its asset base. We calculate it from two lines in the same filing, and a company is only ranked here if it reported both.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth −24.6%
Calculated from two reported figures, so it has no single filing of its own.
Free cash flow at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Organon free cash flow |url=https://companiesranked.com/en/company/organon/free-cash-flow |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Organon free cash flow. CompaniesRanked. https://companiesranked.com/en/company/organon/free-cash-flowBibTeX
@misc{companiesranked-en-company-organon-free-cash-flow-2026,
author = {{CompaniesRanked}},
title = {{Organon free cash flow}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/organon/free-cash-flow}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.